The present invention relates to new medical uses of morphinans such as naltrexone, nalmefene and their related derivatives. The present invention relates to Toll-like receptor 4 (TLR4) antagonist co...
申请号：DK10765221专利类型：发明授权公开（公告）日：2010-04-15
状态：寻求转化转让价格：面议
The present disclosure generally relates to the medical use of compositions comprising a mineral salt and a sulfonic acid for prevention and/or treatment of one or more mucosal diseases, disorders, ...
申请号：RU2018103884专利类型：发明申请公开（公告）日：
状态：寻求转化转让价格：面议
The invention provides a method of preparing a lyophilized pharmaceutical composition containing a dinucleotide compound or a pharmaceutically-acceptable salt thereof. The process comprises dissolving...
申请号：RU2017121460专利类型：发明申请公开（公告）日：
状态：寻求转化转让价格：面议
The present invention relates to pyridinecarboxamide derivatives, a preparation method thereof and a pharmaceutical use thereof. Specifically, the present invention relates to pyridinecarboxamide de...
申请号：JP2019533376专利类型：发明申请公开（公告）日：
状态：寻求转化转让价格：面议
申请号：VN1201805401专利类型：其他公开（公告）日：
状态：寻求转化转让价格：面议
申请号：DK15153281专利类型：发明授权公开（公告）日：
状态：寻求转化转让价格：面议
The present invention relates to antimicrobial peptides of the general formula AxByCz with x, z≥1, y≥3 and x+y+z≤50, where A and C, in each case independently of one another, have at least 65% ba...
申请号：DK14821058专利类型：发明授权公开（公告）日：
状态：寻求转化转让价格：面议
The present invention provides fatty acid derived compounds capable of binding to the PDZ domains of PSD-95 and their medical use as inhibitors of protein-protein interaction mediated by PSD-95.
申请号：DK15801833专利类型：发明授权公开（公告）日：
状态：寻求转化转让价格：面议
The present invention relates to nanoparticles for encapsulating biologically active compounds, comprising a matrix of new polymer conjugates. The invention also relates to a process for producing bo...
申请号：RU2017144895专利类型：发明申请公开（公告）日：
状态：寻求转化转让价格：面议
The invention relates to the field of medicine and medical technology, specifically to bone tissue implants, and can be used in surgery, orthopaedics and dentistry. Bone implants manufactured from ...
